Maurizio Voi

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

Caroline Robert, Jean‐Jacques Grob, Daniil Stroyakovskiy et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +17

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

James C. Yao, Nicola Fazio, Simron Singh et al. · The Lancet · 2015 · 1.3K citations

Medicine, Oncology, Surgery +12

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study

Jacqueline A. French, John A. Lawson, Hiroko Ikeda et al. · The Lancet · 2016 · 747 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Prevalence of <i>ESR1</i> Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer

Sarat Chandarlapaty, David Chen, Wei He et al. · JAMA Oncology · 2016 · 495 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

Robert J. Motzer, Naomi B. Haas, Frede Donskov et al. · Journal of Clinical Oncology · 2017 · 387 citations

Medicine, Oncology, Pharmacotherapy +15